N
National Allergy and Asthma Research LLC | North Charleston, SC
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Dupilumab
OPN-375
Bradanicline
EVO756
Rocatinlimab
CDX-0159
BMX-010
Symbicort®
EP262
NOC-110
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 21 total trials
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).
Enrolling
Chronic Spontaneous Urticaria
Drug: EVO756
Drug: Placebo control
This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...
Enrolling
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo
Trial sponsors
A
E
A
B
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems